Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Episurf Medical

0.04 SEK

-2.89 %

Less than 1K followers

EPIS B

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-2.89 %
-10.65 %
-0.54 %
+23.41 %
-23.12 %
-49.94 %
-96.97 %
-98.06 %
-98.98 %

Episurf Medical operates in the medical technology industry and focuses on the development and manufacture of individually adapted implants for joint repair. The company's products are aimed at surgeons and healthcare institutions. The business is global with a main presence in Europe, North America and Asia. Episurf Medical was founded in 2008 and is headquartered in Stockholm, Sweden.

Read more
Market cap
103.71M SEK
Turnover
138.73K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10.4.
2026

General meeting '26

24.4.
2026

Interim report Q1'26

24.8.
2026

Interim report Q2'26

All
Press releases
3rd party
ShowingAll content types
Regulatory press release2/27/2026, 10:45 AM

Change in number of shares and votes in Episurf Medical

Episurf Medical
Press release2/25/2026, 7:30 AM

New US patent approval for Episurf Medical

Episurf Medical
Regulatory press release2/24/2026, 9:15 AM

The Board of Directors of Episurf has resolved on an issue of Class B shares, convertible debentures and warrants as part of the consideration for the acquisition of real estate assets

Episurf Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release2/23/2026, 3:15 PM

Episurf Medical AB announces outcome of exercise of warrants of series TO14 B

Episurf Medical
Regulatory press release2/23/2026, 7:30 AM

Members of the Nomination Committee for Episurf Medical's Annual General Meeting 2026

Episurf Medical
Regulatory press release2/10/2026, 9:40 AM

Episurf Medical announces leadership changes effective from 11 February 2026

Episurf Medical
Regulatory press release2/10/2026, 8:55 AM

Press release from extraordinary general meeting in Episurf Medical AB (publ)

Episurf Medical
Press release2/9/2026, 7:30 AM

The exercise period for warrants of series TO14 B in Episurf commences today

Episurf Medical
Regulatory press release2/6/2026, 7:30 AM

Episurf: YEAR-END REPORT 1 JANUARY - 31 DECEMBER 2025

Episurf Medical
Regulatory press release1/26/2026, 7:00 AM

Episurf acquires properties with an agreed property value of MSEK 897 from KlaraBo

Episurf Medical
Regulatory press release1/8/2026, 4:50 PM

Notice of Extraordinary General Meeting of Episurf Medical AB (publ)

Episurf Medical
Regulatory press release1/8/2026, 4:40 PM

Episurf has completed the first closing of the acquired real estate assets, convenes an extraordinary general meeting and announces a board change

Episurf Medical
Regulatory press release12/30/2025, 1:35 PM

Episurf forms a new strategic business segment through the acquisition of real estate assets. The purchase price of SEK up to 1,147 million is partly paid through shares, convertibles and warrants

Episurf Medical
Press release11/18/2025, 10:45 AM

Update on Episurf Medical's MTP implant

Episurf Medical
Press release11/4/2025, 7:45 AM

Episurf's implants market approved in Singapore

Episurf Medical
Regulatory press release11/2/2025, 8:30 PM

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Press release10/27/2025, 1:20 PM

Redeye: Episurf Medical (Q3 review) - Growing the US customer base

Episurf Medical
Regulatory press release10/24/2025, 6:30 AM

Episurf: Interim Report 1 January - 30 September 2025

Episurf Medical
Press release10/17/2025, 6:45 AM

Episurf: Scientific article on Episealer® Knee with up to 10 years' follow-up published

Episurf Medical
Press release10/12/2025, 8:00 PM

Board Member Resigns from the Board of Episurf Medical

Episurf Medical
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.